NCT06136065View on ClinicalTrials.gov

68 Gallium-Fibroblast Activating Protein Inhibitors-46 Positron Emission Tomography - Computerized Tomography for Molecular Assessment of Fibroblast Activation and Risk Assessment in Solid Tumors

PHASE2RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

August 21, 2023

Primary Completion Date

August 31, 2025

Study Completion Date

September 30, 2025

Conditions
Solid Tumor, Unspecified, Adult
Interventions
DIAGNOSTIC_TEST

68 Gallium -Fibroblast Activating Protein Inhibitor -46 Positron emission tomography / Computerized tomography

68 Gallium -Fibroblast Activating Protein Inhibitor -46 Positron emission tomography / Computerized tomography scan

Trial Locations (2)

47014

RECRUITING

"IRCCS Istituto ROmagnolo per lo Studio dei Tumori Dino Amadori-IRST S.r.l.", Meldola

59100

ACTIVE_NOT_RECRUITING

"Azienda USL Toscana Centro - SOC Medicina Nucleare - Nuovo Ospedale Santo Stefano", Prato

All Listed Sponsors
lead

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

OTHER